Biologic therapy-Related demyelinating peripheral neuropathy in a child with Juvenile Idiopathic Arthritis
Open Access
- 1 January 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 2 (1), 020-022
- https://doi.org/10.29328/journal.apps.1001008
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS)Seminars in Arthritis and Rheumatism, 2016
- Safety of biologic therapies for the treatment of juvenile idiopathic arthritisExpert Opinion on Drug Safety, 2015
- Biologic agents therapy for Saudi children with rheumatic diseases: indications and safetyInternational Journal of Rheumatic Diseases, 2014
- Peripheral neuropathies during biologic therapiesModern Rheumatology, 2013
- Severe Guillain–Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based reviewClinical Rheumatology, 2013
- Pattern of demyelination occurring during anti-TNF-α therapy: a French national surveyRheumatology, 2013
- Biologics-induced autoimmune diseasesCurrent Opinion in Rheumatology, 2013
- Mecanismo de acción de abatacept: concordancia con su perfil clínicoReumatología Clínica, 2012
- The safety profile of biologic therapies for juvenile idiopathic arthritisNature Reviews Rheumatology, 2010
- Autoimmune diseases induced by biological agents: A double-edged sword?Autoimmunity Reviews, 2010